By analyzing two independent samples – one with a generally low Aβ burden (Add‐Tau cohort) and another in more advanced disease stages with a high Aβ burden (ADNI cohort) – our study highlights that hypertension adversely affects brain health through both AD pathology‐dependent and AD pathology‐independent pathways. This evidence concerns the gene MAPT and hypertensive disorder.